latest news releases from the newsroom
Northrim BanCorp, Inc.
Northrim BanCorp Reports Second Quarter Profits of $1.4 Million, or $0.23 Per Share
ANCHORAGE, Alaska, July 24, 2008 (PRIME NEWSWIRE) -- Northrim BanCorp, Inc. (Nasdaq:NRIM) today reported a decline in its earnings due to lower net interest income and higher loan loss provisions and expenses that were offset in part by an increase in other operating income. After a $2.0 million provision for loan loss reserves and a $977,000 write down associated with other real estate owned ("OREO") projects, second quarter net income was $1.4 million, or $0.23 per diluted share, compared to net income of $3.1 million, or $.48 per diluted share, after a $1.3 million provision for loan loss reserves in the second quarter of 2007. For the first half of 2008, Northrim earned $3.6 million after booking a $3.7 million provision for loan loss reserves, or $0.56 per diluted share, compared to net income of $5.9 million after taking a $1.8 million provision for loans loss reserves, or $0.90 per diluted share, in the like period a year ago.
Outokumpus delårsrapport för andra kvartalet 2008 - förbättrat rörelseresultat på en svagare marknad
Juli 24, 2008 kl 13.15
Andra kvartalet i korthet
- Rörelseresultatet uppgick till 174 milj. euro.
- Bra nettokassaflöde på 103 milj. euro från den operativa verksamheten.
- Avmattad efterfrågan på rostfritt stål från senarelagda inköp i
distributionssektorn till följd av sjunkande nickelpris samt på grund av sämre
efterfrågan från vissa slutanvändarsegment.
- Mindre gradvisa ökningar av baspriset uppnåddes under början av kvartalet,
baspriset började sjunka i ju
Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. Announces New Commercial Spider Silk Report
LANSING, Mich., July 24, 2008 (PRIME NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) announced today the availability of a new research report on the viability of the production of commercial quantities of spider silk and on Kraig Biocraft's role relative to the development of this technology. The report, issued by Emerging Growth Research, LLP provides an overview of the company, its technologies, and a background on the markets the company seeks to address.
NASDAQ OMX Group to Complete Acquisition of The Philadelphia Stock Exchange
NEW YORK, July 24, 2008 (PRIME NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), announced that it intends to complete its acquisition of The Philadelphia Stock Exchange today, expanding The NASDAQ OMX Group's presence in the derivatives market. The Philadelphia Stock Exchange, which will be renamed NASDAQ OMX PHLX, is the nation's oldest stock exchange, and with this acquisition NASDAQ OMX will operate the third largest options market in the U.S. NASDAQ OMX PHLX will be part of the NASDAQ Transaction Services U.S. group. It will continue as a distinct entity alongside The NASDAQ Options Market, launched in March 2008. With this transaction, NASDAQ OMX Group has a combined 17% market share in the U.S. equity options market between its two market models and a much larger footprint in global derivatives.
Integra LifeSciences Holdings Corporation
Integra LifeSciences Announces Agreement to Acquire Theken Spine
PLAINSBORO, N.J., July 24, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash at closing, subject to certain adjustments, and up to $125 million in future payments based on the performance of the business after closing. The future payments will be tied to revenues of the business in the two years after closing. The acquisition is expected to be completed in the third calendar quarter of 2008.